Scholarlink

Aim <p>Diverticulitis, considered a benign condition, has emerging evidence linking it to colorectal cancer (CRC). Current guidelines lack standardised risk stratification tools to guide post-diverticulitis surveillance. This study aims to create and validate a nomogram to predict CRC risk in patients with diverticulitis.</p> Method <p>This retrospective cohort study included 1546 patients diagnosed with diverticulitis at a UK tertiary hospital between January 2021 and December 2023. Patients aged ≥ 18&#xa0;years who underwent endoscopic assessment following a diverticulitis episode were included. A logistic regression model with L2 regularisation and balanced class weights (<i>C</i> = 0.1) was developed to predict a binary outcome: high CRC risk (histologically confirmed cancer) versus low/moderate risk (no cancer), designed to guide referral for flexible sigmoidoscopy (FS).</p> Results <p>The mean age of the cohort was 69.2&#xa0;years, with near-equal sex distribution. CRC was identified in 42 patients (2.7%). Significant predictors of high CRC risk included older age, male sex, and CT-detected colonic wall thickening, whereas abdominal pain, PR bleeding, and diverticulosis were associated with lower risk. The model achieved a cross-validated mean AUC of 0.736 (95% CI 0.661–0.811) and full-sample AUC of 0.784. At the Youden-optimal threshold (0.523), sensitivity was 72.1% and specificity 73.8%.</p> Conclusion <p>We developed and internally validated a nomogram to predict CRC risk in patients with diverticulitis, using a binary classification to guide FS referral. The tool demonstrated robust discriminative ability and could reduce unnecessary colonoscopies while prioritising high-risk patients for timely evaluation. Unlike existing CRC risk models targeting asymptomatic individuals, our nomogram is tailored to diverticulitis patients. External validation in multi-centre cohorts is required before adoption into routine clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and internal validation of a nomogram to predict colorectal cancer risk in patients with diverticulitis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月23日

查看全文
  • Muhammad Usman,
  • Elon Correa,
  • Wen Yuan Chung,
  • Sayyada Nuha Farazi,
  • Konstantinos Baronos,
  • Lasitha Samarakoon,
  • Sudarshan Rao Kadri

摘要

Aim

Diverticulitis, considered a benign condition, has emerging evidence linking it to colorectal cancer (CRC). Current guidelines lack standardised risk stratification tools to guide post-diverticulitis surveillance. This study aims to create and validate a nomogram to predict CRC risk in patients with diverticulitis.

Method

This retrospective cohort study included 1546 patients diagnosed with diverticulitis at a UK tertiary hospital between January 2021 and December 2023. Patients aged ≥ 18 years who underwent endoscopic assessment following a diverticulitis episode were included. A logistic regression model with L2 regularisation and balanced class weights (C = 0.1) was developed to predict a binary outcome: high CRC risk (histologically confirmed cancer) versus low/moderate risk (no cancer), designed to guide referral for flexible sigmoidoscopy (FS).

Results

The mean age of the cohort was 69.2 years, with near-equal sex distribution. CRC was identified in 42 patients (2.7%). Significant predictors of high CRC risk included older age, male sex, and CT-detected colonic wall thickening, whereas abdominal pain, PR bleeding, and diverticulosis were associated with lower risk. The model achieved a cross-validated mean AUC of 0.736 (95% CI 0.661–0.811) and full-sample AUC of 0.784. At the Youden-optimal threshold (0.523), sensitivity was 72.1% and specificity 73.8%.

Conclusion

We developed and internally validated a nomogram to predict CRC risk in patients with diverticulitis, using a binary classification to guide FS referral. The tool demonstrated robust discriminative ability and could reduce unnecessary colonoscopies while prioritising high-risk patients for timely evaluation. Unlike existing CRC risk models targeting asymptomatic individuals, our nomogram is tailored to diverticulitis patients. External validation in multi-centre cohorts is required before adoption into routine clinical practice.